Breaking Down G1 Therapeutics: 5 Analysts Share Their Views
Breaking Down G1 Therapeutics: 5 Analysts Share Their Views
分解 G1 疗法：5 位分析师分享他们的观点
In the preceding three months, 5 analysts have released ratings for G1 Therapeutics (NASDAQ:GTHX), presenting a wide array of perspectives from bullish to bearish.
在过去的三个月中，有5位分析师发布了G1 Therapeutics（纳斯达克股票代码：GTHX）的评级，提出了从看涨到看跌的各种观点。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表简要介绍了他们最近的收视率，展示了过去30天中不断变化的情绪，并将其与前几个月进行了比较。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $10.8, along with a high estimate of $14.00 and a low estimate of $4.00. Surpassing the previous average price target of $9.50, the current average has increased by 13.68%.
分析师提供了更深入的见解，确定了12个月的目标股价，平均目标价为10.8美元，最高估计为14.00美元，低估值为4.00美元。超过了之前的平均目标股价9.50美元，目前的平均价格上涨了13.68％。
Deciphering Analyst Ratings: An In-Depth Analysis
解密分析师评级：深度分析
An in-depth analysis of recent...
对分析师近期...
登录免费看全文
登录/注册